期刊文献+

内皮素-1反义脱氧寡核苷酸对糖尿病肾病大鼠肾组织形态学的影响 被引量:5

Protective effects of endothelin-1 mRNA antisense oligodeoxynucleotide on the kidney ultrustructure of streptozotocin-induced diabetic nephropathy rats
下载PDF
导出
摘要 目的:研究内皮素-1反义脱氧寡核苷酸(ET-1AS-ODN)对链脲佐菌素(streptozotocin,STZ)诱导的糖尿病大鼠肾组织形态学的保护作用及其机制.方法:一次性腹腔注射STZ(60mg/kg),建立大鼠糖尿病模型,观察ET-1AS-ODN预防性给药对大鼠肾组织形态结构的保护作用.结果:ET-1AS-ODN可明显减轻糖尿病大鼠肾肥大指数,改善肾组织形态学损伤.结论:内皮素-1反义寡核苷酸可减轻STZ诱导的糖尿病肾病大鼠的肾损伤,对肾组织具有保护作用.其机制与减少内源性内皮素的产生有关. AIM: To investigate the protective effects of endothelin-1 mRNA antisense oligodeoxynucleotide (ET-1 AS-ODN ) on the renal morphology of diabetic nephropathy(DN) and discuss the pathogenesis and mechanism of DN in a diabetic rat model. METHODS: Diabetic rats were induced by intraperitoneal administration of streptozotocin (STZ) at 60 mg/kg. ET-1 AS-ODN was administrated intravenously to the treatment groups and its protective effects on renal morphology were observed. RESULTS: Compared with the DM group, the kidney index reduced significantly the general condition and morphological injury improved significantly in ET-1 AS-ODN treatment groups. CONCLUSION: Endothelin-1 mRNA antisense oligodeoxynucleotide has a protective effect on the kidney by preventing renal impairment in diabetic nephropathy rats. The mechanism of the protective effect of Endothelin-1 mRNA antisense oligodeoxynucleotide involves inhibition of endogenous ET-1 production.
出处 《第四军医大学学报》 北大核心 2009年第20期2090-2092,共3页 Journal of the Fourth Military Medical University
基金 宁夏高等学校科学技术研究项目(宁教高[2007]292号-103 宁教高[2007]292-87) 宁夏卫生厅重点科研计划项目(W2008087) 宁夏医科大学科学技术研究项目(XM200832)
关键词 内皮素-1反义寡核苷酸 糖尿病肾病 形态学 内皮素 endothelin-1 mRNA antisense oligodeoxynucleotide diabetic nephropathy morphology endothelin
  • 相关文献

参考文献2

二级参考文献28

  • 1戴德哉,吉民,黄敏,刘立钢.内皮素受体拮抗剂CPU0213的生物活性及抑制ETA及ETB受体的作用(英文)[J].中国药科大学学报,2004,35(6):552-557. 被引量:10
  • 2方敬爱,邓安国,刘建社.益肾胶囊治疗早期糖尿病肾病的临床研究[J].中国中西医结合肾病杂志,2005,6(8):457-459. 被引量:15
  • 3李永强,黄海长,白秀珍,蒋洪.足细胞与糖尿病肾病[J].中国中西医结合肾病杂志,2005,6(12):739-741. 被引量:6
  • 4Lemley KV, Blouch K, Abdullah I, et al. Glomerular perm selectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol, 2000,11 ( 11 ) : 2095 - 2105.
  • 5Meyer TW,Bennett PH, Nelson RG. Podocyte number predicts long - term urinary albumin excretion in Pima Indians with type Ⅱ diabetes and microalbuminuria. Diabetologia, 1999,42 ( 11 ):1341 - 1344.
  • 6Steffes MW, Schmidt D, McCrery R, et al. Glomerular cell number in normal subjects and in type Ⅰ diabetic patients. Kidney Int. 2001, 59(6) :2104 -2113.
  • 7Mifsud SA, Allen TJ, Bertam JF, et al. Podocyte foot process boadening in experimental diabetic nephropathy: amelioration with renin - angiotensin blockade. Diabetologia, 2001,44 ( 7 ) : 878 - 882.
  • 8Kerjaschki D, Poezewski H, Dekan G, et al. Identification of a major sialoprotein in the glycocalyx of human visceral glomeru-lar epithelial cells. J Clin Invest, 1986,78(5): 1142 - 1149.
  • 9Gross ML, El - Shakmak A, Szabo A, et al. ACE inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia, 2003,46 (6): 856 - 868.
  • 10Sugimoto K ,Tsuruoka S, Fujimura A. Effect of enalapril on diabetic nephropathy in OLETF rats: the role of an anti- oxidative action in its protective properties. Clin Exp Pharmacol Physiol, 2001,28(10) :826.

共引文献29

同被引文献48

  • 1闫惠忠,齐国先,闻秀丽,付尧,孔宏亮.代谢综合征患者循环内皮细胞和血浆NOS/NO系统及内皮素改变[J].中国现代医学杂志,2008,18(23):3533-3535. 被引量:7
  • 2王建富,高文献,李晶,秦连芝,李钦萍,胡爱东,刘成华.高压氧治疗对冠状动脉支架置入术后支架内再狭窄的影响[J].中华物理医学与康复杂志,2005,27(12):757-759. 被引量:7
  • 3Jefferson JA, Shankland SJ, Piehler RH. Proteinuria in diabetic kidney disease : a mechanistic viewpoint [ J ]. Kidney Int, 2008,74 (1) :22 -36.
  • 4Siemianowicz K, Francuz T, Gminski J, et al. Endothelium dysfunction markers in patients with diabetic retinopathy [ J ]. Int J Mol Med,2005,15 (3) :459 - 462.
  • 5Goligorsky MS,Chen J,Brodsky S.Workshop:endothelial cell dysfunction leading to diabetic nephropathy:focus on nitric oxide[J].Hypertension,2001,37(2):744-748.
  • 6Raptis AE,Viberti G.Pathogenesis of diabetic nephropathy[J].Exp Clin Endocrinol Diabetes,2001,109 Suppl 2:S424-437.
  • 7Neuhofer W,Pittrow D.Role of endothelin and endothelin receptor antagonists in renal disease[J].Eur J Clin Invest,2006,36 Suppl 3:S78-88.
  • 8Ak G,Buyukberber S,Sevinc A,et al.The relation between plasma endothelin-1 levels and metabolic control,risk factors,treatment modalities,and diabetic microangiopathy in patients with type 2 diabetes mellitus[J].J Diabetes Complications,2001,15(3):150-157.
  • 9Bruno CM,Meli S,Marcinno M,et al.Plasma endothelin-1 levels and albumin excretion rate in normotensive,microalbuminuric type 2 diabetic patients[J].J Biol Regul Homeost Agents,2002,16(2):114-117.
  • 10Zaidi M,Datta H,Bevis PJ.Kidney:a target organ for calcitonin gene-related peptide[J].Exp Physiol,1990,75(1):27-32.

引证文献5

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部